000			02063 a2200625 4500
005			20250516171330.0
264		0	_c20140220
008			201402s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2013.09.007 _2doi
040			_aNLM _beng _cNLM
100	1		_aMa, Brigette B Y
245	0	0	_aPreclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models. _h[electronic resource]
260			_bCancer letters _cFeb 2014
300			_a24-32 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCarcinoma
650	0	4	_aCell Cycle
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival
650	0	4	_aCisplatin _xpharmacology
650	0	4	_aEnzyme Activation
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aInhibitory Concentration 50
650	0	4	_aMAP Kinase Signaling System
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aNasopharyngeal Carcinoma
650	0	4	_aNasopharyngeal Neoplasms _xgenetics
650	0	4	_aNeoplasm Transplantation
650	0	4	_aPaclitaxel _xpharmacology
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aQuinolines _xpharmacology
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
700	1		_aLui, Vivian W Y
700	1		_aHui, Connie W C
700	1		_aLau, Cecilia P Y
700	1		_aWong, Chi H
700	1		_aHui, Edwin P
700	1		_aNg, Margaret H L
700	1		_aCheng, Suk H
700	1		_aTsao, Sai W
700	1		_aTsang, Chi-Man
700	1		_aCheung, Crystal S F
700	1		_aHo, Kakiu
700	1		_aChan, Anthony T C
773	0		_tCancer letters _gvol. 343 _gno. 1 _gp. 24-32
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2013.09.007 _zAvailable from publisher's website
999			_c23093888 _d23093888